Deep Functional Phenotyping of the ALA Lung Health Cohort
Deep Functional Phenotyping of the ALA Lung Health Cohort
批准号:
10685503
负责人:
Charles G Irvin
金额:
$69.14万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-15 至 2027-07-31
关键词:
AdultAgeAir PollutionAllergic rhinitisAncillary StudyAsthmaBlood VesselsBody mass indexCOVID-19Carbon MonoxideCardiacChildChildhood AsthmaChronic Obstructive Pulmonary DiseaseChronic lung diseaseCohort StudiesCommunitiesDataDiffusionDiseaseDisease ProgressionElectronic cigaretteEnvironmental Risk FactorEthnic OriginExerciseFundingFutureGasesGoalsGrowthHeartHeart AtriumImpairmentIndividualInfrastructureInvestigationKnowledgeLeftLeft Ventricular MassLinkLongitudinal cohortLungLung CapacityLung diseasesMarijuanaMeasuresMorphologyNational Heart, Lung, and Blood InstituteNatureObesityOscillometryOxygenOxygen saturation measurementParentsParticipantPathogenesisPersonsPhenotypePredispositionPrevention strategyPublic HealthPulmonary Function Test/Forced Expiratory Volume 1QuestionnairesRecording of previous eventsRespiratory Signs and SymptomsRisk FactorsRoleSmokerSpirometryStructureStructure of parenchyma of lungTobaccoValidationWalkingX-Ray Computed Tomographyairway hyperresponsivenesschronic respiratory diseasecohortheart dimension/sizeinjured airwayinnovationinsightlung healthlung volumeprematurepreventpulmonary functionrecruitsexyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
An individual can progress from ideal lung health, to an intermediate phenotype of impaired lung health, to
chronic respiratory disease, yet this transition is poorly understood. A consequence of this knowledge gap is the
lack of robust strategies to prevent chronic lung disease. The Lung Health Cohort (LHC) study (NHLBI
5U01HL146408) will recruit healthy participants across the US to have their lung health evaluated through
questionnaires, biospecimen analysis, spirometry, and computerized tomography (CT), and relate these features
to an array of anthropomorphic and environmental factors thought to influence lung health. In this Ancillary study
application, we propose to extend the phenotyping of the LHC to include detailed measures of lung
structure and function to obtain a more robust understanding of the influence of modifiable exposures
and risk factors on lung health. We postulate that a key aspect of both current and future lung health is
“dysanapsis”, which is thought to occur when dyssynchronous growth of airways and lung parenchyma such that
the airways are small relative to lung size. Dysanapsis has been associated in children with obesity, airways
hyperresponsiveness and asthma, and in adults, with COPD; however, a comprehensive characterization and
validation of dysanapsis by both more specific functional and structural measures has not been assessed in
healthy young adults nor shown to be a longitudinal risk factor. Our timely and innovative approach will combine
structural information by CT with functional, state-of the-art assessment of spirometry, lung volumes, and
oscillometry and gas exchange. We hypothesize that modifiable exposures and risk factors influence lung
health by their effects on structural and functional dysanapsis of the airway, parenchyma and pulmonary
vasculature and gas exchange. In particular, we will assess the associations of modifiable environmental
factors such as tobacco, air pollution, marijuana and electronic cigarettes, in addition to age, sex, ethnicity, BMI,
prematurity, allergic rhinitis, and history of COVID-19, as these factors relate to airway and vascular dysanapsis,
cardiac morphology and gas exchange. The plausible mechanistic hypothesis that underlies the proposal is that
there is mismatching of airways and blood vessels to parenchyma both in terms of structure (CT) and function
(PFTs); we posit that this dysanapsis is a silent marker of early and progressive lung disease. This ancillary
study will leverage the infrastructure and endpoints of the parent LHC study, as we will extend the LHC
investigation in a number of significant ways to fill knowledge gaps that determine both the reserve and
susceptibility of the lung to disease. This “deep phenotyping” of the baseline lung function and cardiac and
pulmonary vascular structure will provide a more detailed understanding of the influence of modifiable exposures
and risk factors of both current and future lung disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IDeA Entrepreneurship Training and Community Development
-
批准号:10703427
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2022
-
负责人:Charles G Irvin
-
依托单位:
IDeA Entrepreneurship Training and Community Development
-
批准号:10516248
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2022
-
负责人:Charles G Irvin
-
依托单位:
TRANSLATIONAL RESEARCH IN LUNG BIOLOGY AND DISEASE
-
批准号:8364916
-
项目类别:
-
资助金额:$112.55万
-
财政年份:2011
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:8126199
-
项目类别:
-
资助金额:$112.55万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:8137515
-
项目类别:
-
资助金额:$14.24万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:7939084
-
项目类别:
-
资助金额:$113.69万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:8542877
-
项目类别:
-
资助金额:$107.28万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:8723247
-
项目类别:
-
资助金额:$109.31万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:8138205
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:8319673
-
项目类别:
-
资助金额:$113.1万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology and Disease
-
批准号:9333156
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2010
-
负责人:Charles G Irvin
-
依托单位:
COBRE: UVT: ADMINISTRATIVE & INTELLECTUAL & ENVIRONMENTAL
-
批准号:7959620
-
项目类别:
-
资助金额:$45.81万
-
财政年份:2009
-
负责人:Charles G Irvin
-
依托单位:
PILOT PROJECT AND EMERGING OPPORTUNITIES
-
批准号:7959626
-
项目类别:
-
资助金额:$11.86万
-
财政年份:2009
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology
-
批准号:7920731
-
项目类别:
-
资助金额:$45.03万
-
财政年份:2009
-
负责人:Charles G Irvin
-
依托单位:
Translational Research in Lung Biology
-
批准号:7920730
-
项目类别:
-
资助金额:$19.67万
-
财政年份:2009
-
负责人:Charles G Irvin
-
依托单位:
COBRE: UVT: ADMINISTRATIVE & INTELLECTUAL & ENVIRONMENTAL
-
批准号:7720873
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2008
-
负责人:Charles G Irvin
-
依托单位:
COBRE: UVT: ADMINISTRATIVE & INTELLECTUAL & ENVIRONMENTAL
-
批准号:7609697
-
项目类别:
-
资助金额:$34.32万
-
财政年份:2007
-
负责人:Charles G Irvin
-
依托单位:
COBRE: UVT: ADMINISTRATIVE & INTELLECTUAL & ENVIRONMENTAL
-
批准号:7381075
-
项目类别:
-
资助金额:$37.81万
-
财政年份:2006
-
负责人:Charles G Irvin
-
依托单位:
National IDeA Symposium of Biomedical Excellence (NISBRE)
-
批准号:8209026
-
项目类别:
-
资助金额:$32.61万
-
财政年份:2005
-
负责人:Charles G Irvin
-
依托单位:
National IDeA Symposium of Biomedical Research Excellence (NISBRE)
-
批准号:7126371
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2005
-
负责人:Charles G Irvin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: